My watch list

Anecortave

Anecortave
Systematic (IUPAC) name
[2-[(8R,10S,13S,14R,17R)- 17-hydroxy-10,13-dimethyl-3-oxo- 2,6,7,8,12,14,15,16-octahydro- 1H-cyclopenta[a]phenanthren-17-yl]- 2-oxo-ethyl] acetate
Identifiers
CAS number	7753-60-8
ATC code	S01XA16
PubChem	111332
DrugBank	?
Chemical data
Formula	C₂₃H₃₀O₅
Mol. mass	386.48
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status	Schedule 4 (Aust)
Routes	intravitreal depot injection

Anecortave (rINN) (pronounced /ænəˈkɔrteɪv/) is a novel angiogenesis inhibitor used in the treatment of the exudative (wet) form of age-related macular degeneration. Although based on a steroid nucleus, it possesses little glucocorticoid activity. It is marketed by Alcon as anecortave acetate for depot suspension under the trade name Retaane.